(0)Quest

(0)Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Phone: 561.366.0084 Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Requisition: 0006872 Collected: Received: Reported: 11/23/2018 11/27/2018 109:51 EST 11/28/2018 109:22 EST Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Test Hams In Range Out Of Range PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS PROTEIN, TOTAL, SERUM Reference Range Lab MI PROTEIN, TOTAL 7.1 6.1-8.1 g/dL PROTEIN ELECTROPHORESIS ALBUMIN 4.2 3.8-4.8 g/dL TP ALPHA 1 GLOBULIN 0.3 0.2-0.3 g/dL ALPHA 2 GLOBULIN 0.7 0.5-0.9 g/dL BETA 1 GLOBULIN 0.6 0.4-0.6 g/dL BETA 2 GLOBULIN 0.4 0.2-0.5 g/dL GAMMA GLOBULIN 1.0 0.8-1.7 g/dL INTERPRETATION Normal Electrophoretic Pattern The above test was performed; however, the specimen was lipemic. LIPID PANEL, STANDARD CHOLESTEROL, TOTAL 216 H <200 mg/dL MI HDL CHOLESTEROL 23 L >40 mg/dL MI TRIGLYCERIDES 935 H <150 mg/dL MI LDL-CHOLESTEROL mg/dL (talc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 9.4 H NON HDL CHOLESTEROL 193 H For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.1 <5.0 (talc) <130 mg/dL (talc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular risk according to AHA/CDC guidelines. however, MI MI TP CLIENT SERVICES: 866.697.8378 SPECIMEN: MR8391 ION Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGEI0F6 EFTA00804474 Quest —• Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Collected: 11/23/2018 Received: 11/27/2018 / 09:51 EST Reported: 11/28/2018 / 09:22 EST Client #: 78300020 MOSKOWITZ, BRUCE W Test Name For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 In Range Out Of Range Reference Range Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 12.7 H Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC PANEL GLUCOSE 111 H For someone without known diabetes, a glucose value between 100 and 125 mg/dL is consistent with prediabetes and should be confirmed with a follow-up test. UREA NITROGEN (BUN) 20 CREATININE 0.95 For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT HEMOGLOBIN Ale 84 97 NOT 138 4.4 105 24 9.9 7.1 4.4 2.7 1.6 0.7 60 23 36 APPLICABLE 5.7 H <11.4 umol/L 65-99 mg/dL Fasting reference interval 7-25 mg/dL 0.70-1.25 mg/dL > OR 60 mL/min/1.73m2 > OR 60 mL/min/1.73m2 6-22 (calc) 135-146 mmol/L 3.5-5.3 mmol/L 98-110 mmol/L 20-32 mmol/L 8.6-10.3 mg/dL 6.1-8.1 g/dL 3.6-5.1 g/dL 1.9-3.7 g/dL (calc) 1.0-2.5 (calc) 0.2-1.2 mg/dL 40-115 U/L 10-35 U/L 9-46 U/L <5.7 % of total Hgb Lab MI MI MI CLIENTSERIIICES:866.6971378 SPECIMEN: MR839110N Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 2 OF 6 EFTA00804475 rajQuest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Collected: 11/23/2018 Received: 11/27/2018 109:51 EST Reported: 11/28/2018 / 09:22 EST Client #: 78300020 MOSKOWITZ, BRUCE W Test Name In Range Out Of Range For someone without known diabetes, a hemoglobin Alc value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Alc targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes for children. CALCIUM, IONIZED URIC ACID Therapeutic target for gout IMMUNOFIXATION, SERUM INTERPRETATION 5.2 6.9 patients: <6.0 mg/dL NO MONOCLONAL PROTEIN DETECTED TSH 2.44 T4 (THYROXINE), TOTAL 7.6 FREE T4 INDEX (T7) 2.3 T3 UPTAKE 30 SED RATE BY MODIFIED WESTERGREN 11 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT 6.0 RED BLOOD CELL COUNT 5.28 HEMOGLOBIN 15.4 HEMATOCRIT 44.3 MCV 83.9 MCH 29.2 MCHC 34.8 RDW 13.0 PLATELET COUNT 273 MPV 10.6 ABSOLUTE NEUTROPHILS 2892 ABSOLUTE LYMPHOCYTES 2298 ABSOLUTE MONOCYTES 492 ABSOLUTE EOSINOPHILS 270 ABSOLUTE BASOPHILS 48 NEUTROPHILS 48.2 LYMPHOCYTES 38.3 MONOCYTES 8.2 EOSINOPHILS 4.5 BASOPHILS 0.8 URINALYSIS, COMPLETE Sim Endhoto I IRON AND TOTAL IRON BINDING CAPACITY Reference Range 4.8-5.6 mg/dL 4.0-8.0 mg/dL 0.40-4.50 mIU/L 4.9-10.5 mcg/dL 1.4-3.8 22-35 % < OR = 20 mm/h 3.8-10.8 Thousand/uL 4.20-5.80 Million/uL 13.2-17.1 g/dL 38.5-50.0 % 80.0-100.0 fL 27.0-33.0 pg 32.0-36.0 g/dL 11.0-15.0 % 140-400 Thousand/uL 7.5-12.5 fL 1500-7800 cells/uL 850-3900 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL Lab TP MI TP MI MI MI MI MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR839110N Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE30F6 EFTA00804476 Quest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Collected: 11/23/2018 Received: 11/27/2018 / 09:51 EST Reported: 11/28/2018 / 09:22 EST Client #: 78300020 MOSKOWITZ, BRUCE W Test Name IRON, TOTAL IRON BINDING CAPACITY % SATURATION FERRITIN VITAMIN B12 In Range 91 336 27 57 325 Out Of Range Reference Range 50-180 mcg/dL 250-425 mcg/dL (calc) 15-60 % (calc) 20-380 ng/mL 200-1100 pg/mL Please Note: Although the reference range for vitamin B12 is 200-1100 pg/mL, it has been reported that between 5 and 10% of patients with values between 200 and 400 pg/mL may experience neuropsychiatric and hematologic abnormalities due to occult B12 deficiency; less than 1₹ of patients with values above 400 pg/mL will have symptoms. C-REACTIVE PROTEIN MERCURY, BLOOD Lab MI MI 1.3 <8.0 mg/L MI <5 <OR=10 mcg/L AT This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. PSA, TOTAL 0.6 < OR = 4.0 ng/mL MI The total PSA value from this assay system is standardized against the WHO standard. The test result will be approximately 20% lower when compared to the equimolar-standardized total PSA (Beckman Coulter). Comparison of serial PSA results should be interpreted with this fact in mind. This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. TESTOSTERONE, FREE (DIALYSIS) AND TOTAL,MS TESTOSTERONE, TOTAL, MS 153 L 250-1100 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly in the range of the 200-300 ng/dL or less, may benefit from testosterone treatment after adequate risk and benefits counseling. For additional information, please refer to http://education.questdiagnostics.com/faq/ TotalTestosteroneLCMSMSFAQ165 (This link is being provided for informational/ educational purposes only.) This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Chantilly, VA. It has not been cleared or approved by the U.S. Food and Drug AMD CLIENTSERIIICES:866.697.8378 SPECIMEN: MR839110N PAGE 4 OF 6 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00804477 Quest —00 Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: Collected: Received: Reported: MR839110N 11/23/2018 11/27/2018 I 09:51 EST 11/28/2018 / 09:22 EST Test Name In Range Out Of Range Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. TESTOSTERONE, FREE Endnote I 42.5 This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute Chantilly, VA. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. * Test not performed. * No specimen received. * * Client Information Client #: 78300020 MOSKOWITZ, BRUCE W Reference Range 35.0-155.0 pg/mL Lab CLIENT SERVICES: 866.697.8378 SPECIMEN: MR8391 ION Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE5OF6 EFTA00804478 rajQuest Diagnostics Report Status: Final EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 65 Gender: M Patient ID: 19530120MJE Health ID: 8573003290851249 Specimen: MR8391 ION Collected: 11/23/2018 Received: 11/27/2018 / 09:51 EST Reported: 11/28/2018 / 09:22 EST Client #: 78300020 MOSKOWITZ, BRUCE W Endocrinology Test Name VITAMIN D,25-OH,TOTAL,IA Vitamin D Status Result 24 L Reference Range 30-100 ng/mL Lab MI Deficiency: Insufficiency: Optimal: For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: httpJ/education.questdiagnostics.com/faq/FAO163 (This link is being provided for informational/ educational purposes only.) 25-OH Vitamin D: <20 ng/mL 20 - 29 ng/mL > or = 30 ng/mL Physician Comments: PERFORMING SITE: AMD QUEST DIAGNOSTICS/NIOIOLS CHANTILLY. 1422.5 NEWBROOK DRJVE CHANTILL Y. VA 201 SI -2225 Laboratory Ducar PATRICK W. MASONAID.PHD.CLIA: 1900221801 AT QUEST DIAGNOSTICS...JUNTA. 1777 MONTREAL CIRCLE. IIICICER GA 30014.6802 Laboratory Director. ANDREW N YOUNG.AID.PHD.CLIA: 1100255931 MI QUEST DIAGNOSTICS.NIIAMI HMO COMMERCE PARKWAY. MIRAMAR. FL 330254938 Laboratory DUCCIOI: JULIE I. FRIEDMAN.MD.CLIA: If/002773M TP QUEST DIAGNOSTICSTAMPA.1223 E FOWLER AVE TAMPA. It 33617.2026 Laboratory Ihrector GLEN L IIORTIN.MD.PHD. CUA: 1000291120 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR839110N PAGE 6 OF 6 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00804479